Why the study?
COVID-19 in people with diabetes is associated with a disproportionately worse prognosis, but little is known about the natural history of DKA in the presence of COVID-19.
Does COVID-19 infection worsen the clinical course and outcomes of diabetic ketoacidosis in patients with type 1 and type 2 diabetes?
Does COVID-19 infection worsen the clinical course and outcomes of diabetic ketoacidosis in patients with type 1 and type 2 diabetes?
COVID-19 infection in patients with DKA is associated with more severe hyperglycemia in type 1 diabetes and significantly higher ICU admission and mortality in type 2 diabetes.
No takes yet. Share an insight, caveat, or question.
May warrant type-specific vigilance in COVID-associated DKA; leaves open causal mechanisms and need for prospective validation.
Kempegowda et al. (2021) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: